These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22677324)

  • 1. Bilateral vertebral artery dissection and essential thrombocythemia with JAK2 mutation.
    Verdure P; Lefaucheur R; Guegan-Massardier E; Triquenot-Bagan A; Gerardin E; Maltête D
    Rev Neurol (Paris); 2012 Jun; 168(6-7):543-4. PubMed ID: 22677324
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeated episodes of ischemic stroke over a short period in a patient with essential thrombocythemia on anticoagulant therapy.
    Naganuma M; Isoda K; Nishi S; Ito K; Hirano T
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):166-8. PubMed ID: 22898586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.
    Henry L; Carillo S; Jourdan E; Arnaud A; Brun S; Lavabre-Bertrand T
    Am J Hematol; 2007 Jun; 82(6):500-1. PubMed ID: 17301972
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia.
    Adam R; Priglinger M; Harrington T; Gottlieb D; Krause M
    J Stroke Cerebrovasc Dis; 2014; 23(5):e373-4. PubMed ID: 24582788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential thrombocythemia: scientific advances and current practice.
    Tefferi A
    Curr Opin Hematol; 2006 Mar; 13(2):93-8. PubMed ID: 16456375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2 mutations and coronary ischemia.
    Lata K; Madiraju N; Levitt L
    N Engl J Med; 2010 Jul; 363(4):396-7. PubMed ID: 20660412
    [No Abstract]   [Full Text] [Related]  

  • 7. Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation.
    Au WY; Fung A; Lam KY; Lie AK; Liang R; Kwong YL
    Bone Marrow Transplant; 2006 Oct; 38(8):573-4. PubMed ID: 16953212
    [No Abstract]   [Full Text] [Related]  

  • 8. Essential thrombocythemia - a predisponent factor for stroke.
    Batista TFP; Manuel PF; Correia AC
    Rev Assoc Med Bras (1992); 2019 Jul; 65(6):772-774. PubMed ID: 31340302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral vertebral artery dissection possibly precipitated in delayed fashion as a result of roller coaster rides.
    Schneck M; Simionescu M; Bijari A
    J Stroke Cerebrovasc Dis; 2008; 17(1):39-41. PubMed ID: 18190821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy.
    Girodon F; Schaeffer C; Cleyrat C; Mounier M; Lafont I; Santos FD; Duval A; Maynadié M; Hermouet S
    Haematologica; 2008 Nov; 93(11):1723-7. PubMed ID: 18728027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.
    Allegra A; Alonci A; Penna G; D'Angelo A; Rizzotti P; Granata A; Musolino C
    Acta Haematol; 2009; 121(4):218-20. PubMed ID: 19478480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Bilateral Vertebral Artery Dissection Associated with Essential Thrombocythemia.
    Raza HK; Jing J; Chen H; Zhu J; Zhang Z; Chansysouphanthong T; Cui G; Hua F; Ye X; Shi H; Jiang H
    J Neurol Surg A Cent Eur Neurosurg; 2020 Jan; 81(1):75-79. PubMed ID: 31170738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Images in neuroscience. Vertebral artery dissection.
    Seneviratne J; Ferdinands M
    J Clin Neurosci; 2005 Jan; 12(1):47-8. PubMed ID: 15639412
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Cacciola E; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
    Ann Hematol; 2010 Feb; 89(2):141-6. PubMed ID: 19582452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mutant JAK2 allele burden in children with essential thrombocythemia.
    Teofili L; Cenci T; Martini M; Capodimonti S; Torti L; Giona F; Amendola A; Randi ML; Putti MC; Scapin M; Leone G; Larocca LM
    Br J Haematol; 2009 May; 145(3):430-2. PubMed ID: 19208099
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia.
    Ricksten A; Palmqvist L; Johansson P; Andreasson B
    Haematologica; 2008 Aug; 93(8):1260-1. PubMed ID: 18519514
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral vertebral artery dissection causing a cerebrovascular accident in pregnancy. A case report.
    Mass SB; Cardonick E; Haas S; Gopalani S; Leuzzi RA
    J Reprod Med; 1999 Oct; 44(10):887-90. PubMed ID: 10554752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of femoral fracture in a patient with essential thrombocythemia treated with plateletpheresis and intramedullary rod fixation, followed by hydroxyurea: a case report.
    Edlich RF; Long WB; Cochran AA; Kelley AR; Woode DR; Greene JA; Takahashi GW
    Am J Emerg Med; 2008 Jun; 26(5):636.e1-3. PubMed ID: 18534315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation.
    Nishihori T; Hassoun Y; Zhang L; Shain K; Alsina M; Kharfan-Dabaja MA
    Bone Marrow Transplant; 2014 Jan; 49(1):148-9. PubMed ID: 23933759
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia.
    Albizua E; Gallardo M; Barrio S; Rapado I; Jimenez A; Ayala R; Rueda D; Sanchez-Espiridion B; Puigdecanet E; Espinet B; Florensa L; Besses C; Martinez-Lopez J
    Ann Hematol; 2011 Aug; 90(8):939-46. PubMed ID: 21331593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.